Sectorial split

Not available

Factsheet

SRRI risk indicator ²

Investment policy

The Product seeks to outperform the 20% EURO STOXX 50 + 80% Bloomberg Euro Aggregate 1-10 years composite index calculated with dividends and coupons reinvested, over the recommended investment period. Investors’ attention is drawn to the fact that the management style is discretionary and integrates environmental, social / societal and governance (ESG) criteria. The overall investment strategy of the Product is to seek to enhance the return on a patrimonial investment through the active management of a portfolio of equities and fixed income products. It aims to provide an alternative to investments in bonds and convertibles bonds (directy or through mutual funds) as well as an alternative to funds benefitting from a capital guarantee. The Product however dos not benefit from a guarantee on capital invested. The Product is also managed taking into consideration Responsible and Sustainable principles and promotes environmental and/or social characteristics within the meaning of Article 8 of SFDR. The investment process take into account internal scoring based on an extra-financial analysis through a proprietary rating model (ABA, Above & Beyond Analysis) developed internally by DNCA. The risk exists that the models used to make these investment decisions do not perform the tasks they were designed to. The use of the proprietary tool relies on the experience, relationships and expertise of DNCA with the "best in universe" method. There may be a sector bias. The Product will proceed to the extra-financial analysis on at least 90% of its securities, while excluding 20% of the worst issuers from its investment universe. Additional information on SRI strategy may be obtained in the prospectus of the Product. The following limits apply: For up to 100% of its net assets, the Product may be exposed to fixed income securities. Within the limit the fixed income securities may mostly be denominated in Euro, composed of securities issued by public or private issuers, and be incorporated in a country which is an OECD member state, without any ranting constraint including non-rated issues; For up to 50% of its net assets the Product may be exposed to securities belonging to the “speculative grade” category (i.e. which have a rating below a Standard & Poor’s minimum A-3 short term or BBB- long term rating or equivalent) or non-rated. The Management Company shall not solely base its investment decisions on ratings assigned by independant rating agencies, but shall take them into account in its decision. The Management Company can also proceed to its own credit risk assessment; For up to 35% of its net assets, the Product may be exposed to equities. Within this limit, the equities may moslty be issued by issuers incorporated in OECD members states, belonging to all market capitalisations catergories, and denominated in Euro. Investment in equities issued by issuers which marketcapitalisation is under 1 billion Euros may not exceed 5% of the net assets of the Product. Up to 5% of its net assets, the Product may be exposed to securities which may qualify as distressed securities (i.e. which have a Standard & Poor’s rating below CCC long-term rating or equivalent).The aggregate exposure to equities incorporated in non-OECD members states and/or (ii) fixied income securities issued by issuers incorporated in a non-OECD member state and/or guaranteed by a non-OECD member state, may not exceed 10% of the net asset of the Product. The Product may invest up to a limit of 10% of its net assets, in securities denominated in currencies other than the Euro (including, but not limited to, the U.S. dollar, the Pound sterling and the Swiss franc). As such, the Product may be exposed to exchange risk on an ancillary basis. Up to 10% of its net assets in contingent convertibles bonds. The duration of the Product's portfolio will be limited to 7 years. The Product may invest up to 10% of its net assets in units and/or shares of UCITS and/or other UCIs including ETFs.In order to achieve the investment objective, the Product may invest in equities or related financial derivative instruments for the purpose of hedging or increasing equity or interest rate risk without seeking overexposure. The Product may also be exposed up to 100% of its net assets to financial derivative instruments or OTC derivatives such as, but not limited to, futures, options, CDS, CDS on indices, negotiated on regulated or OTC markets, for hedging or investment purposes (e.g. increasing equity exposure, interest rate risk, credit risk, without seeking overexposure). The Product may also be exposed to up to a maximum of 5% of its net assets in commodities (including gold) through investments in mutual funds.The Product is actively managed and uses the benchmark for performance comparison purposes. This means the Management Company is taking investment decisions with the intention of achieving the Product’s investment objective; this may include decisions regarding asset selection and overall level of exposure to the market. The Management Company is not in any way constrained by the benchmark in its portfolio positioning. The deviation from the benchmark may be complete or significant. This is an accumulation share

The investment policy of the fund is extracted from the KIID